3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Thrombosis
1
Thromboembolism
1
Prostatic Neoplasms
1
Neoplasms
1
Lung Neoplasms
1
Inflammation
1
Immune System Diseases
1
Colonic Neoplasms
1
Cardiovascular Diseases
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Interventions
palbociclib
2
Blood Pressure
2
xinmailong
1
ribociclib
1
abemaciclib
1
Vitamin D
1
Social Determinants of Health
1
Rivaroxaban
1
Restraint, Physical
1
Raloxifene Hydrochloride
1
Quality of Life
1
Progestins
1
Progesterone
1
Positron-Emission Tomography
1
Patient Navigation
1
Linseed Oil
1
Hormone Replacement Therapy
1
High-Intensity Interval Training
1
Heart Rate
1
Heart Function Tests
1
Genetic Testing
1
Exercise
1
Estrogens
1
Estrogen Replacement Therapy
1
Estradiol
1
Dietary Supplements
1
Diet, Fat-Restricted
1
Calcium
1
Anthracyclines
1
Absorptiometry, Photon
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cardiovascular Diseases
×
Rivaroxaban
×
Breast
×
Clear all
NCT06065592
2023-10-06
CAT_PB
Lebanese University
Phase 1
Unknown
500 enrolled